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Background: Prior studies of tricuspid regurgitation (TR) after endocardial lead placement have been limited by small sample size and have been 
unable to identify predictors of its occurrence. This study sought to describe the incidence of worsening TR following implantation of endocardial 
leads for permanent pacemakers (PPM) and implantable cardioverter-defibrillators (ICD) and to identify clinical and echocardiographic risk factors 
that predict significantly increased TR follwing lead placement.
methods: Patients (N=405) who received a PPM or ICD from 01/2006 to 12/2010, and had echocardiograms both within 1 year prior to and any 
time after device placement were included. TR was assessed on a 6-point scale (none/trace, mild, mild to moderate, moderate, moderate to severe, 
severe). The primary outcome was an increase in the severity of TR by 2 or more grades.
results: A significant increase in TR was seen in 52 (12.8%) patients. Table 1 shows pre-implant patient features grouped by the change in 
severity of TR with lead placement. Univariate predictors of increased TR were age and atrial fibrillation. In a multivariate analysis, pre-implant atrial 
fibrillation (odds ratio = 2.13, p=0.015, 95% confidence interval 1.16-3.96) was the only independent predictor.
conclusions: The incidence of significant increased TR following endocardial lead placement was 12.8%; this is lower than prior estimates. Pre-
implant atrial fibrillation predicts increased TR after lead placement.
 
